Clinical trials
Shock clinical trials
Below are recruiting shock clinical trials, each written for real people, not researchers. We’re tracking 313 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07597291Recruiting
Understanding heart failure shock outcomes and treatments
This registry tracks patients experiencing cardiogenic shock—a serious condition where the heart suddenly cannot pump enough blood to the body. Researchers collect information about patient outcomes and treatments to better understand what helps people recover.
Carnaxide, Lisbon DistrictAges 18 years+ - NCT07626645Recruiting
Shock wave therapy for leg swelling from lymphedema
This trial tests whether extracorporeal shock wave therapy—a non-invasive treatment that uses sound waves—can help reduce swelling in the legs caused by lymphedema. You would receive this treatment while continuing your current compression therapy.
Ankara, YenimahalleAges 18–80 - NCT07616817Enrolling by invitation
Expert Panel Study on Ultrasound Assessment of Septic Shock
This study gathers expert opinions from critical care doctors and specialists around the world who use bedside ultrasound (a portable imaging tool) to diagnose and categorize septic shock (a life-threatening infection condition). The goal is to develop standardized approaches to identifying different types of septic shock using ultrasound.
Albany, New YorkAges Any age - NCT07401758Recruiting
Shockwave therapy for knee tendon pain
This study tests whether a noninvasive treatment called shockwave therapy can help reduce pain and improve function in people with patellar tendinitis, a common overuse injury of the knee tendon. It may be a good option for you if you have moderate knee pain and are otherwise healthy.
Guangzhou, GuangdongAges 18–45 - NCT07354568Recruiting
Mixed heart and blood vessel shock study
This study looks at people with a severe type of shock that affects both the heart and blood vessels, treated in the intensive care unit. It aims to understand how these patients recover and what factors impact their survival.
Amiens, SommeAges 18 years+ - NCT07090382Enrolling by invitation
Predicting shock risk in heart attack patients
This study uses an AI tool to predict which patients with a heart attack might develop cardiogenic shock, a serious complication where the heart can't pump enough blood. It aims to help doctors identify high-risk patients early.
BratislavaAges 18 years+ - NCT05931601RecruitingPhase 3
Early blood-pressure support in the emergency department
This Phase 3 study tests whether starting a blood-pressure medicine earlier in the emergency room can improve outcomes for people with low blood pressure or shock. It focuses on patients who have already received enough IV fluids and meet specific blood pressure and lab findings.
CopenhagenAges 18 years+ - NCT06587412Recruiting
Shock Wave Therapy for Chronic Tennis Elbow
This trial tests if shock wave therapy can help people with long-term tennis elbow (pain on the outside of the elbow lasting more than 3 months). The treatment is a non-invasive option that may reduce pain and improve function.
Alcalá de Henares, MadridAges 18–70 - NCT03378739Recruiting
Registry study for cardiogenic shock care at Inova
This study collects information about how cardiogenic shock is treated in the hospital at Inova (for sudden worsening heart failure or a heart attack). It may help improve care for future patients, because the research team will learn what treatments and outcomes are associated with different situations.
Falls Church, VirginiaAges 18–85 - NCT07750080Recruiting
Comparing two therapies for tennis elbow in menopausal women
This study tests whether a combination of electrical therapies or shock wave therapy works better for reducing pain and improving function in menopausal women with tennis elbow that has lasted at least 3 months.
CairoAges 45–55 - NCT07643610Recruiting
Heart Failure Crisis Registry Study
This registry collects information from patients admitted to the hospital with cardiogenic shock—a serious condition where the heart cannot pump enough blood to the body. Doctors will gather data to better understand what happens to these patients and how to improve their care.
Basel, Canton of Basel-CityAges 18 years+ - NCT05969275RecruitingPhase 2
Cell therapy trial for infection-related septic shock in ICU
This Phase 2 trial tests an immune-boosting cell therapy (umbilical mesenchymal stromal cells) in people with septic shock—when infection causes dangerous stress on the heart and other organs. The goal is to see if this treatment can improve outcomes compared with standard care.
Ottawa, OntarioAges 18 years+ - NCT06062303Recruiting
Capillary refill time to guide septic shock treatment
This trial tests a new way of giving fluids and medicines to people with septic shock. It focuses on a simple sign called capillary refill time (how fast color returns when you press a fingernail) to guide treatment, aiming to improve recovery.
ReimsAges 18 years+ - NCT06124599Recruiting
Early signs of menstrual toxic shock syndrome
This study looks at what happens in the days just before menstrual toxic shock syndrome starts. If you are a young woman who uses tampons or cups and recently got very sick with fever, rash, and low blood pressure during your period, you may be able to join as a case participant.
LyonAges 13–30 - NCT07563764Recruiting
Shock Wave Therapy for Overactive Bladder in Women
This study tests whether low-energy shock wave therapy can reduce frequent urination, nighttime bathroom trips, and sudden urges to urinate in women who also have metabolic syndrome (a combination of conditions like high blood pressure, high blood sugar, and extra belly fat). The therapy is non-invasive and may offer an alternative to medications or injections.
Kaohsiung, TaiwanAges 20–75 - NCT07468734Recruiting
Shock wave vs. physical therapy for knee arthritis
This study compares two treatments for chronic knee osteoarthritis: shock wave therapy and traditional physical therapy. The goal is to see which one helps reduce pain and improve function better.
CairoAges 40 years+ - NCT07451886RecruitingPhase 2
Fludrocortisone for septic shock
This study tests whether adding a steroid called fludrocortisone to standard care helps people with septic shock (a dangerous drop in blood pressure from infection) get better faster. If you are in the ICU, on a breathing machine, and need strong medication for your blood pressure, you may be eligible.
Hong KongAges 18 years+ - NCT07273526Recruiting
Adrenaline vs. Dopamine for septic shock in children
This study compares two medicines, adrenaline and dopamine, to see which works better for children with septic shock (a serious infection causing very low blood pressure) that does not improve with fluids.
Faisalābad, Punjab ProvinceAges 1 month–1 year - NCT07255378Recruiting
Vasopressin for septic shock in the ICU
This study observes how the medication vasopressin works when added to standard treatment for septic shock in the ICU. It helps doctors understand if vasopressin improves outcomes for patients with severe infection and low blood pressure.
Terrassa, BARCELONAAges 18 years+ - NCT05465200Recruiting
Study for cardiogenic shock treatment in adults under 24 hours
This trial is testing a treatment approach for adults with cardiogenic shock, a life-threatening condition where the heart can’t pump enough blood. You may be considered if your shock started within the last 24 hours and you meet other safety criteria.
WroclawAges 18–60 - NCT07203833Recruiting
Vasorin test for shock diagnosis and outlook
This study looks at a protein called vasorin in the blood to see if it can help diagnose and predict outcomes in people with severe shock in the ICU. It compares patients with septic shock (caused by infection) to those with shock from other causes.
AmiensAges 18 years+ - NCT04750070RecruitingPhase 3
Treating shock in young children with severe malnutrition and diarrhea
This study tests a treatment approach to help children who are in “shock” (their body is struggling to maintain blood flow and oxygen) caused by diarrhea and severe undernutrition. It may help care teams stabilize children faster and improve outcomes.
DhakaAges 1 month–4.9 years - NCT06937918Recruiting
Fluid management guide for septic shock patients
This study tests a computer software that helps doctors decide how much fluid to give patients in septic shock. It aims to improve blood pressure and oxygen delivery without causing fluid overload.
Bangkok Noi, BangkokAges 18 years+ - NCT07085221Recruiting
Remote monitoring for early cardiogenic shock recovery
This trial tests whether digital out-of-hospital management improves outcomes for patients who have recovered from early-stage cardiogenic shock. If you have been discharged after treatment for this condition and can use a smartphone, you may be eligible.
Wuhan, HubeiAges 18 years+
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for shock?
- Yes. Clin2 currently lists 313 recruiting shock studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a shock trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a shock trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.